Label: DIPHENHYDRAMINE HCL ORAL SOLUTION solution
- NDC Code(s): 81033-029-16
- Packager: Kesin Pharma Corporation
- This is a repackaged label.
- Source NDC Code(s): 84447-103
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated March 4, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Purpose
- Uses
- WARNINGS
-
DIRECTIONS
- do not take more than directed
- find the right dose on the chart below
- mL = milliliter
- take every 4 to 6 hurs, or as directed by a doctor
- do not take more than 6 doses in 24 hours
Age (yr) Doses (mL) children under 2 years do not use children 2 to 5 years do not use unless directed by a doctor children 6 to 11 years 5 mL to 10 mL - Other Information
- Inactive ingredients
- Questions or comments?
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
DIPHENHYDRAMINE HCL ORAL SOLUTION
diphenhydramine hcl oral solution solutionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:81033-029(NDC:84447-103) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIPHENHYDRAMINE HCL (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) DIPHENHYDRAMINE HCL 12.5 mg in 5 mL Inactive Ingredients Ingredient Name Strength METHYLPARABEN (UNII: A2I8C7HI9T) SUCRALOSE (UNII: 96K6UQ3ZD4) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) PROPYLPARABEN (UNII: Z8IX2SC1OH) ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) SORBITOL (UNII: 506T60A25R) AMMONIUM GLYCYRRHIZATE (UNII: 3VRD35U26C) POTASSIUM CITRATE (UNII: EE90ONI6FF) Product Characteristics Color Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:81033-029-16 473 mL in 1 BOTTLE; Type 0: Not a Combination Product 03/04/2025 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 03/04/2025 Labeler - Kesin Pharma Corporation (117447816)


